THE TRUTH ABOUT: Soleno - Caught on Camera

Prader-Willi Drug Vykat XR: FDA Case Reports Describe 7 Deaths and Nearly 100 Hospitalizations, but Cause Is Unproven

FDA case reports describe seven deaths and nearly 100 hospitalizations in people prescribed Vykat XR for Prader-Willi syndrome. Here is what families should know.

Medical Daily · Oct 15

Soleno Under Serious Scrutiny As Short Seller Alleges PWS Drug Is Overpriced, Unsafe

Soleno Therapeutics Inc. (NASDAQ:SLNO) shares fell on Friday following a short report from Scorpion Capital, which criticized the company's only product, Vykat XR, as overpriced and potentially unsafe for children with Prader-Willi syndrome (PWS).

Benzinga · Aug 15, 2025

3 Top Small-Cap Tech Picks for Investors This Month

Wall Street believes these three small companies have significant upside potential.

Barchart · Jul 26, 2024